VU 0255035

CAS : 1135243-19-4

Ref. 3D-KVB24319

Informations sur le produit

• Nom: VU 0255035
• CAS: 1135243-19-4

Description

VU0255035 is a drug that blocks the muscarinic acetylcholine receptor, which is used to treat diabetic neuropathy. The development of VU0255035 was based on the identification of a monoclonal antibody that selectively binds to the M1 muscarinic acetylcholine receptor and blocks its activity. VU0255035 has been shown to inhibit locomotor activity in animals, which may be due to its ability to inhibit acetylcholine release from cholinergic nerve endings. This drug also inhibits the production of inflammatory molecules such as nitric oxide and prostaglandin E2 in animal models. VU0255035 has also been shown to be effective in treating autoimmune diseases such as multiple sclerosis, rheumatoid arthritis, and psoriasis. In addition, it may have potential for cancer therapy as it has been shown to inhibit tumor growth and induce apoptosis in various cancer cell lines.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 432.52 g/mol
• Formule: C₁₈H₂₀N₆O₃S₂
• Degré de pureté: Min. 95%